Neisseria meningitidis can be serologically divided into at least 12 immunotypes (L1 through L12) based on its lipooligosaccharides (LOS). Some of meningococcal LOS mimic a human glycosphingolipid, paragloboside, in having lacto-N-neotetraose (LNnT, Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc) sequence as a part of the oligosaccharide structures of the LOS. We previously reported that eight of the twelve LOS types were bound an LNnT- specific monoclonal antibody (anti-My-28). The expression of the antibody- reactive epitope in the LOS was influenced by growth conditions and the LNnT epitope could be masked at the nonreducing end by sialic acid which was identified as N-acetyl-neuraminic acid (NANA). We have further investigated the linkage between the sialic acid and LNnT using linkage- specific lectins, Maackia amurensis agglutinin (MAA, for sialylalpha2- >3Gal..) and Sambucus nigra agglutinin (SNA, for sialylalpha2->6Gal..). Six of the eight LNnT-antibody reacting LOS bound MAA lectin but not SNA lectin indicating that NANA is alpha2->3 linked to LNnT sequence in the LOS. Therefore, many N. meningitidis LOS mimic human glycosphingolipids, paragloboside and sialoparagloboside (NANAalpha2->3paragloboside), in having in the same oligosaccharide sequences in their structures. The presence of these sequences in the LOS may play a role in the virulence of N. meningitidis by enabling the organism to evade host immune defenses.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BJ002008-09
Application #
3770279
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1993
Total Cost
Indirect Cost